L2P Research provides R&D support in all the key areas of Pharmaceutical development. We offer proprietary orthotopic and metastatic tumor models. Our services include, Quantitative whole body animal imaging, small animal ultra sound MRI, CT scan, Focal radiation and other advanced technologies. We provide a complete array of research services as required for Investigational New Drug Applications (IND). We are head quartered at Stony Brook New York. Our other facilities include Valhalla, NY (Custom animal model development ) and Syracuse, NY (Surgical services) . We operate in AAALAC accredited and GLP compliant audited facilities. L2P Research Currently offers these services: 1) In vitro studies: Tissue culture, Cell Isolation and cell line maintenance Serological and Immunochemistry analysis Immune assays (ELISA, EIA) Lead Optimization (IC50/assays) Flow Cytometry/FACS analysis 3D culture, Angiogenesis Inhibition assays 2) In vivo studies: Xenograft and Orthotropic tumor models Wide range of fully characterized cell lines to use in our animal studies ADME/TOX QWBA Immune assays (ELISA, EIA) Fully tested Bioluminescence (BLS) and fluorescent (FLS) studies Example dosage routes – Oral, I.P., I.V., I.T., I.M., S.C., Infusion etc., Species – Mice, Rat, Non-Human Primates (NHP’s) - Rabbit, Mini pigs, Canines,